| __timestamp | BioMarin Pharmaceutical Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 129764000 | 117418000 |
| Thursday, January 1, 2015 | 152008000 | 102526000 |
| Friday, January 1, 2016 | 209620000 | 105386000 |
| Sunday, January 1, 2017 | 241786000 | 110188000 |
| Monday, January 1, 2018 | 315264000 | 121544000 |
| Tuesday, January 1, 2019 | 359466000 | 127930000 |
| Wednesday, January 1, 2020 | 524272000 | 148917000 |
| Friday, January 1, 2021 | 470515000 | 440760000 |
| Saturday, January 1, 2022 | 483669000 | 540517000 |
| Sunday, January 1, 2023 | 577065000 | 435577000 |
| Monday, January 1, 2024 | 580235000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. BioMarin Pharmaceutical Inc. and Jazz Pharmaceuticals plc, two industry leaders, have shown distinct trends in their cost of revenue from 2014 to 2023. BioMarin's cost of revenue surged by approximately 345% over this period, peaking in 2023. In contrast, Jazz Pharmaceuticals experienced a more modest increase of around 270%, with a notable peak in 2022. This divergence highlights BioMarin's aggressive expansion strategy, while Jazz maintains a steadier growth trajectory. The data reveals that BioMarin consistently outpaced Jazz in cost of revenue, particularly from 2020 onwards, suggesting a potential focus on scaling operations. As the pharmaceutical industry evolves, understanding these financial dynamics is crucial for stakeholders aiming to navigate this complex market.
Cost of Revenue Comparison: Gilead Sciences, Inc. vs Jazz Pharmaceuticals plc
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs BioMarin Pharmaceutical Inc.
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Jazz Pharmaceuticals plc
Cost of Revenue Trends: BeiGene, Ltd. vs BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: BioMarin Pharmaceutical Inc. vs ADMA Biologics, Inc.
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs PTC Therapeutics, Inc.
BioMarin Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: BioMarin Pharmaceutical Inc. vs Wave Life Sciences Ltd.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Galapagos NV
BioMarin Pharmaceutical Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc.
Cost of Revenue Trends: Jazz Pharmaceuticals plc vs Viridian Therapeutics, Inc.